Vaccine for mutated H5N1 strain enters human trials by end of 2025?
Yes • 50%
No • 50%
Clinical trial registries such as ClinicalTrials.gov or announcements from pharmaceutical companies
California Researchers Find Mutation in H5N1 Bovine Strains Could Enable Human Transmission
Dec 5, 2024, 09:04 PM
Researchers from the Scripps Research Institute, including California-based scientists, have identified a single mutation in the H5N1 bird flu virus that could enable it to bind more effectively to human cell receptors. This mutation, found in bovine strains of the virus circulating in the United States, could potentially allow the virus to infect human upper airways and facilitate human-to-human transmission. The findings, published in the journal Science, highlight the need for heightened surveillance of both avian and bovine versions of H5N1 to mitigate the risk of a future pandemic.
View original story
Vaccine approved • 34%
No vaccine introduced • 33%
Vaccine in development • 33%
No • 50%
Yes • 50%
Yes, by a major pharmaceutical company • 25%
No vaccine developed • 25%
Yes, by a university or research institution • 25%
Yes, by a government agency • 25%
World Health Organization • 25%
Other • 25%
Scripps Research Institute • 25%
Centers for Disease Control and Prevention • 25%
China • 25%
United States • 25%
Other • 25%
India • 25%